| Literature DB >> 24224006 |
Eun Ju Lee1, Majid Rasool Kamli, Smritee Pokharel, Adeel Malik, K M A Tareq, Abdul Roouf Bhat, Hee-Bok Park, Yong Seok Lee, SangHoon Kim, Bohsuk Yang, Ki Young Chung, Inho Choi.
Abstract
BACKGROUND: Muscle satellite cells (MSCs) represent a devoted stem cell population that is responsible for postnatal muscle growth and skeletal muscle regeneration. An important characteristic of MSCs is that they encompass multi potential mesenchymal stem cell activity and are able to differentiate into myocytes and adipocytes. To achieve a global view of the genes differentially expressed in MSCs, myotube formed-cells (MFCs) and adipocyte-like cells (ALCs), we performed large-scale EST sequencing of normalized cDNA libraries developed from bovine MSCs.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24224006 PMCID: PMC3818215 DOI: 10.1371/journal.pone.0079780
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic diagram for EST data analysis.
Overview of DNA Sequencing.
|
|
|
|
| |
|---|---|---|---|---|
|
| 8,064 | 8,064 | 8,064 | 24,192 |
|
| 7,974 | 7,991 | 7,954 | 23,919 |
| Total length (bp) | 6,381,878 | 6,451,798 | 6,371,036 | 19,204,712 |
| Average length (bp) | 788 | 792 | 776 | |
|
| ||||
| Clusters | 1,128 | 1,139 | 1,066 | 3,333 |
| Singletons | 2,098 | 1,750 | 1,669 | 5,517 |
| Contigs | 1,318 | 1,287 | 1,237 | 3,842 |
MSC: muscle satellite cell, MFC: myotube-formed cell, ALC: adipocyte-like cell.
List of genes showing more than tenfold difference in ESTs between MSC vs.
MFC/ALC or MFC vs. ALCs.
| Accession ID | MSC | MFC | ALC | M Analysis | Annotation |
|---|---|---|---|---|---|
|
| 44 | 33 | 0 | 6 (MFC) | Myosin regulatory light chain 2, skeletal muscle isoform (MYLPF) |
|
| 16 | 0 | 2 | ND | Calmodulin 2 (CaM) |
|
| 14 | 1 | 7 | 2 (ALC) | Cytochrome c oxidase subunit I (Cox1) |
|
| 13 | 1 | 5 | ND | Ribosomal protein L6-like |
|
| 12 | 9 | 1 | ND | 60S ribosomal protein L6 (RPL6) |
|
| 10 | 1 | 1 | ND | Thioredoxin-dependent peroxide reductase, mitochondrial precursor (AOP-1) |
|
| 10 | 0 | 2 | ND | Chromobox protein homolog 3 (CBX3) |
|
| 10 | 6 | 1 | ND | Nucleophosmin (NPM1) |
|
| 3 | 32 | 13 | 2 (MFC) | Gap junction alpha-1 protein (GJA1) |
|
| 3 | 29 | 6 | 4 (MFC) | Cathepsin K precursor (CTSK) |
|
| 1 | 20 | 0 | ND | N(G),N(G)-dimethylargininedimethylaminohydrolase 2 (DDAH2) |
|
| 1 | 28 | 22 | 3 (MFC) | Fibronectin1 (FN 1) |
|
| 5 | 17 | 0 | 3 (ALC) | Cathepsin B (CTSB) |
|
| 0 | 15 | 1 | ND | Latent-transforming growth factor beta-binding protein 2 (LTBP2) |
|
| 4 | 15 | 1 | ND | NADH dehydrogenase subunit 5 (ND5) |
|
| 9 | 14 | 0 | ND | Heat shock protein beta-8 (HSPB8) |
|
| 1 | 13 | 4 | ND | Cathepsin K precursor (CTSK) |
|
| 1 | 12 | 8 | 2 (MFC) | Metalloproteinase inhibitor 1 precursor (TIMP-1) |
|
| 0 | 12 | 10 | 2 (MFC) | Diamineacetyltransferase 1 (SAT1) |
|
| 2 | 12 | 1 | 2 (MFC) | Protein S100-A4 (S100A4) |
|
| 2 | 11 | 0 | ND | Tubulin alpha-1B chain (TUBA1B) |
|
| 1 | 10 | 9 | 2 (ALC) | Syndecan-1 precursor (SYND1) |
|
| 3 | 5 | 38 | ND | Decorin precursor (DCN) |
|
| 4 | 10 | 1 | ND | 60S ribosomal protein L9 (PGY2) |
|
| 5 | 10 | 0 | ND | Actin, alpha skeletal muscle (ACTA1) |
|
| 3 | 10 | 0 | ND | V-type proton ATPase subunit d 1 (ATP6V0D1) |
|
| 7 | 10 | 0 | ND | Desmin (DES) |
|
| 5 | 10 | 0 | ND | Selenoprotein M precursor (SELM) |
|
| 0 | 0 | 88 | 3 (MFC) | Pentraxin-related protein PTX3 precursor (PTX3) |
|
| 0 | 4 | 41 | 9 (MFC) | Glutathione peroxidase 3 precursor (GPX3) |
|
| 1 | 0 | 31 | 17 (MFC) | Plasminogen activator inhibitor type 1, member 2 (SERPINE2) |
|
| 14 | 2 | 24 | 2 (MFC) | Galectin-1 (Gal-1) |
|
| 0 | 10 | 19 | ND | Secreted frizzled-related protein 4 isoform 2 (SFRP4) |
|
| 2 | 0 | 17 | 11 (MFC) | Adipose differentiation-related protein (PLIN2) |
|
| 0 | 0 | 15 | 5 (MFC) | Hemoglobin subunit alpha (HBA) |
|
| 0 | 3 | 14 | ND | Clusterinpreproprotein (CLU) |
|
| 0 | 0 | 13 | ND | Lysophospholipidacyltransferase (LPCAT4) |
|
| 0 | 20 | 26 | ND | Serine protease HTRA1 (HTRA1) |
|
| 3 | 1 | 12 | ND | Rab GDP dissociation inhibitor beta (GDI2) |
|
| 1 | 2 | 12 | ND | Member RAS oncogene family (RAB1) |
|
| 0 | 0 | 12 | 11 (MFC) | Fatty acid-binding protein 4 (FABP4) |
|
| 0 | 0 | 11 | ND | Mitochondrial fission 1 protein (FIS1) |
|
| 1 | 4 | 10 | ND | 60S ribosomal protein L18a (RPL18A) |
Numbers indicate ESTs. M analysis represents fold differences in mRNA expression of genes and ND are genes not detected by DNA microarray. MFC and ALC represent fold difference of myotube-formed cells and adipose-like cell during microarray analysis, respectively.
Figure 2KOG analysis of ESTs in MSC, MFC and ALC.
The functions of genes were categorized and each function is represented by the symbols given below: .
[J] Translation, ribosomal structure and biogenesis, [A] RNA processing and modification, [L] replication, recombination and repair, [B] chromatin structure and dynamics, [Y] nuclear structure, [V] defense mechanisms, [T] signal transduction mechanisms, [M] cell wall/membrane/envelope biogenesis, [N] cell motility, [Z] cytoskeleton, [W] extracellular structures, [U] intracellular trafficking, secretion, and vesicular transport, [O] posttranslational modification, protein turnover, chaperones, [C] energy production and conversion, [G] carbohydrate transport and metabolism, [E] amino acid transport and metabolism, [F] nucleotide transport and metabolism, [H] coenzyme transport and metabolism, [I] lipid transport and metabolism, [P] inorganic ion transport and metabolism, [R] general function prediction only, [S] function unknown. The X-axis represents percentage and Y axis represents functional category.
Functional classifications of genes with more than 3 fold differences in ESTs.
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
|
| DAA25054.1 | Signal transduction mechanisms | 0 | 15 | 1 | Latent transforming growth factor beta binding protein 2 (LTBP2) |
| NP_001094594.1 | 0 | 8 | 2 | Death-associated protein kinase 3 (DAPK3) | ||
| AAP44493.1 | 0 | 6 | 0 | Aggrecan (ACAN) | ||
| NP_001029224.1 | 1 | 6 | 1 | Growth hormone inducible transmembrane protein (GHITM) | ||
| NP_001092564.1 | 0 | 6 | 0 | Ras-related protein Rab-7L1(GHITM) | ||
| NP_001033199.1 | 1 | 5 | 1 | Vasodilator-stimulated phosphoprotein (VASP) | ||
| NP_001069325.1 | 0 | 5 | 0 | Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PPP2CB) | ||
| NP_001076899.1 | 0 | 5 | 0 | LETM1 domain-containing protein 1 (LETMD1) | ||
| NP_001095955.1 | 1 | 5 | 0 | Rho GTPase activating protein 29 (ARHGAP29) | ||
| NP_776686.1 | 0 | 5 | 0 | Calpain, small subunit 1 (CAPNS1) | ||
| AFH30757 | Cytoskeleton | 2 | 11 | 0 | Tubulin alpha-1B chain (TUBA1B) | |
| NP_080645 | 0 | 7 | 0 | Actin-related protein 2/3 complex subunit 5 (ARPC5) | ||
| ABM06144 | 0 | 5 | 0 | Myosin regulatory light polypeptide 9 (MYL9) | ||
| NP_001069115 | 0 | 5 | 0 | Myosin regulatory light chain 2, skeletal muscle isoform (MYLPF) | ||
| XP_003586919 | 0 | 4 | 0 | Predicted: plectin-like Protein (PITG) | ||
| NP_001029885 | 1 | 4 | 1 | Actin-related protein 2/3 complex subunit 2 (ARPC2) | ||
| DAA16986 | 0 | 4 | 0 | Filamin B, beta isoform 3 (FLNB) | ||
| NP_001098733.1 | Extracellular structures | 4 | 14 | 4 | 40S ribosomal protein SA (RPSA) | |
|
| 1 | 5 | 1 | Receptor-associated protein of the synapse (RAPSN) | ||
|
| 0 | 3 | 0 | Complement C1q tumor necrosis factor-related protein 3 isoform 1 (C1QTNF3) | ||
|
| NP_001071369.1 | Lipid transport and metabolism | 0 | 0 | 13 | Lysophospholipidacyltransferase (LPCAT4) |
| NP_776739.1 | 0 | 0 | 12 | Fatty acid binding protein 4 (FABP4) | ||
|
| 0 | 0 | 7 | Acyl-CoA synthetase family member 2, mitochondrial precursor (ACSF2) | ||
| NP_001039878.1 | 0 | 0 | 5 | 3-hydroxyisobutyryl-Coenzyme A hydrolase (HIBCH) | ||
| AAL99940.1 | 0 | 0 | 4 | Stearoyl-CoA desaturase (SCD) | ||
|
| 0 | 0 | 4 | Short-chain dehydrogenase/reductase family 42E member 1 (SDR42E1) | ||
| NP_001073689 | 0 | 0 | 4 | Hormone-sensitive lipase (LIPE) | ||
| NP_001069498.1 | Carbohydrate transport and metabolism | 2 | 0 | 7 | 2-oxoglutarate dehydrogenase, mitochondrial precursor (OGDH) | |
| NP_001095385 | 0 | 0 | 4 | Fructose-bisphosphatealdolase A (ALDOA) | ||
|
| 0 | 0 | 4 | Glucose-6-phosphate dehydrogenase (G6PD) | ||
| AAC16069.1 | 0 | 1 | 6 | Glyceraldehyde-3-phosphate dehydrogenase (GAPC1) | ||
| NP_001070890 | Energy production and metabolism | 0 | 0 | 15 | Hemoglobin subunit alpha (HBA) | |
| NP_001017954 | 2 | 2 | 8 | V-type proton ATPase 16 kDaproteolipid subunit (ATP6V0C) | ||
| NP_001039791 | 0 | 0 | 4 | Mitochondrial ornithine transporter 1 (SLC25A15) | ||
| NP_001002891.1 | 0 | 1 | 4 | Cytochrome c oxidase subunit 5A, mitochondrial precursor (COX5A) | ||
| NP_001069834.1 | 0 | 0 | 4 | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) | ||
| AAI04512 | 0 | 0 | 3 | ATP6AP1 protein (ATP6AP1) | ||
| NP_001033671 | 0 | 0 | 3 | Electron transfer flavoprotein subunit beta (ETFB) |
A) MFC vs. MSC/ALC and B) ALC vs. MSC/MFC by KOG. Numbers indicate ESTs.
DAVID Functional Annotation Cluster Analysis.
|
|
|
| |
|---|---|---|---|
|
| GO:0043232~intracellular non-membrane-bounded organelle | 23 | 0.0062 |
| GO:0043228~non-membrane-bounded organelle | 23 | 0.0062 | |
| GO:0005198~structural molecule activity | 21 | 0.0000 | |
| GO:0005576~extracellular region | 16 | 0.0676 | |
| GO:0044421~extracellular region part | 14 | 0.0008 | |
| GO:0006091~generation of precursor metabolites and energy | 13 | 0.0000 | |
| GO:0030529~ribonucleoprotein complex | 13 | 0.0004 | |
| GO:0006412~translation | 12 | 0.0002 | |
| GO:0031012~extracellular matrix | 12 | 0.0000 | |
| GO:0005840~ribosome | 11 | 0.0001 | |
| GO:0005578~proteinaceous extracellular matrix | 11 | 0.0000 | |
| GO:0003735~structural constituent of ribosome | 10 | 0.0001 | |
|
| GO:0005576~extracellular region | 28 | 0.0001 |
| GO:0043232~intracellular non-membrane-bounded organelle | 28 | 0.0058 | |
| GO:0043228~non-membrane-bounded organelle | 28 | 0.0058 | |
| GO:0044421~extracellular region part | 25 | 0.0000 | |
| GO:0031012~extracellular matrix | 21 | 0.0000 | |
| GO:0005578~proteinaceous extracellular matrix | 20 | 0.0000 | |
| GO:0005198~structural molecule activity | 20 | 0.0000 | |
| GO:0005509~calcium ion binding | 20 | 0.0000 | |
| GO:0005856~cytoskeleton | 17 | 0.0081 | |
| GO:0044420~extracellular matrix part | 13 | 0.0000 | |
| GO:0008092~cytoskeletal protein binding | 13 | 0.0000 | |
| GO:0022610~biological adhesion | 11 | 0.0030 | |
| GO:0007155~cell adhesion | 11 | 0.0030 | |
| GO:0006412~translation | 10 | 0.0059 | |
| GO:0030529~ribonucleoprotein complex | 10 | 0.0646 | |
| GO:0001568~blood vessel development | 10 | 0.0000 | |
| GO:0001944~vasculature development | 10 | 0.0000 | |
| GO:0004175~endopeptidase activity | 10 | 0.0140 | |
|
| GO:0005576~extracellular region | 23 | 0.0008 |
| GO:0044421~extracellular region part | 20 | 0.0000 | |
| GO:0031012~extracellular matrix | 17 | 0.0000 | |
| GO:0005198~structural molecule activity | 17 | 0.0000 | |
| GO:0005578~proteinaceous extracellular matrix | 16 | 0.0000 | |
| GO:0005509~calcium ion binding | 12 | 0.0306 | |
| GO:0006091~generation of precursor metabolites and energy | 11 | 0.0001 | |
| GO:0030529~ribonucleoprotein complex | 11 | 0.0094 |
A) MSC233, B) MFC258 and C) ALC248. GO terms having at least 10 genes from the resulting functional clusters and statistically significant p-values are shown.
Figure 3Biochemical pathway analysis of highly expressed gene list.
Representative KEGG pathway for A) MSC, B) MFC and C) ALC.
List of genes specific to A) MSC, B) MFC and C) ALCs.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| NP_777140.1 | 8 | 0 | 0 | 60S ribosomal protein L3 |
| BAE35030.1 | 7 | 0 | 0 | Leucine-rich repeat-containing protein 59 | |
| NP_001040078.1 | 7 | 0 | 0 | Cleft lip and palate transmembrane protein 1 homolog | |
| NP_001095606.1 | 7 | 0 | 0 | Nucleoredoxin | |
| XP_613708.3 | 7 | 0 | 0 | Cartilage-associated protein | |
| CAH56277.1 | 6 | 0 | 0 | Hypothetical protein | |
| EDL84232.1 | 6 | 0 | 0 | Tropomyosin alpha-1 chain | |
| NP_001093789.1 | 6 | 0 | 0 | Ubiquitin carboxyl-terminal hydrolase 4 | |
| NP_001095592.1 | 6 | 0 | 0 | Translocon-associated protein subunit alpha | |
| XP_002118239.1 | 6 | 0 | 0 | Predicted protein | |
| XP_540101.2 | 6 | 0 | 0 | Rho-related GTP-binding protein RhoB | |
| XP_874996.2 | 6 | 0 | 0 | Oxysterol-binding protein-related protein 5 | |
| AAI02075.1 | 5 | 0 | 0 | 60S acidic ribosomal protein P0 | |
| ACE75861.1 | 5 | 0 | 0 | Troponin I, slow skeletal muscle | |
| BAG57729.1 | 5 | 0 | 0 | WD repeat and SOCS box-containing protein 1 | |
| EAW68950.1 | 5 | 0 | 0 | ELAV-like protein 1 | |
| EAW83679.1 | 5 | 0 | 0 | Calumenin | |
| EAW91832.1 | 5 | 0 | 0 | Zinc finger protein 706 | |
| NP_001039509.1 | 5 | 0 | 0 | UMP-CMP kinase | |
| NP_001094577.1 | 5 | 0 | 0 | FARSA protein | |
| NP_777109.1 | 5 | 0 | 0 | ATP synthase subunit alpha, mitochondrial | |
| NP_861528.1 | 5 | 0 | 0 | tRNA (cytosine-5-)-methyltransferase | |
| XP_001082579.1 | 5 | 0 | 0 | Cofilin-2 | |
| XP_001380719.1 | 5 | 0 | 0 | NA* | |
| XP_001788533.1 | 5 | 0 | 0 | Integrin alpha-7 | |
| XP_001790312.1 | 5 | 0 | 0 | Zinc finger MYM-type protein 1 | |
|
| BAG61348.1 | 0 | 8 | 0 | Adapter-related protein complex 3 mu-1 subunit |
| NP_001069211.1 | 0 | 7 | 0 | Translation initiation factor eIF-2B subunit alpha | |
| NP_001106692.1 | 0 | 7 | 0 | RTN4 protein | |
| Q9CPW4.3 | 0 | 7 | 0 | Actin-related protein 2/3 complex subunit 5 | |
| XP_001495008.1 | 0 | 7 | 0 | transcription from RNA polymerase II promoter | |
| XP_541506.2 | 0 | 7 | 0 | Nucleobindin 1 precursor isoform 1 | |
| AAP44493.1 | 0 | 6 | 0 | Aggrecan | |
| NP_001029707.1 | 0 | 6 | 0 | NAD(P)H dehydrogenase, quinone 1 | |
| NP_001032534.1 | 0 | 6 | 0 | ATP-citrate synthase | |
| NP_001092564.1 | 0 | 6 | 0 | RAB7L1 protein | |
| XP_001255518.2 | 0 | 6 | 0 | PREDICTED: zinc finger protein 106 homolog | |
| XP_871977.3 | 0 | 6 | 0 | Uncharacterized protein | |
| XP_875886.2 | 0 | 6 | 0 | PREDICTED: protein FAM101B, partial | |
| AAI12879.1 | 0 | 5 | 0 | Dehydrogenase/reductase SDR family member 4 | |
| ABM06144.1 | 0 | 5 | 0 | Myosin regulatory light polypeptide 9 | |
| BAG56803.1 | 0 | 5 | 0 | RWD domain-containing protein 4 (FAM28A) | |
| EAW78788.1 | 0 | 5 | 0 | hCG1806964, isoform CRA_b | |
| NP_001029875.1 | 0 | 5 | 0 | Elongation of very long chain fatty acids | |
| NP_001069325.1 | 0 | 5 | 0 | Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | |
| NP_001076899.1 | 0 | 5 | 0 | LETM1 domain-containing protein 1 | |
| NP_001096653.1 | 0 | 5 | 0 | Polymerase (DNA-directed), delta interacting protein 3 | |
| NP_776686.1 | 0 | 5 | 0 | Calpain small subunit 1 | |
| NP_874363.1 | 0 | 5 | 0 | Selenoprotein V | |
| P12624.6 | 0 | 5 | 0 | Myristoylated alanine-rich C-kinase substrate | |
| P13605.2 | 0 | 5 | 0 | Fibromodulin | |
| XP_001371068.1 | 0 | 5 | 0 | Myosin regulatory light chain 2 | |
| XP_001491993.2 | 0 | 5 | 0 | PREDICTED: LOW QUALITY PROTEIN: alpha-actinin-2 | |
| XP_875656.2 | 0 | 5 | 0 | zinc finger MYM-type protein 6 | |
|
| NP_001069727.1 | 0 | 0 | 88 | Pentraxin-related protein PTX3 |
| NP_001070890.2 | 0 | 0 | 15 | Hemoglobin subunit alpha | |
| NP_001071369.1 | 0 | 0 | 13 | LPCAT4 protein | |
| NP_776739.1 | 0 | 0 | 12 | Fatty acid-binding protein, adipocyte | |
| XP_001143081.1 | 0 | 0 | 11 | Mitochondrial fission 1 protein | |
| EDL24540.1 | 0 | 0 | 9 | Prostaglandin E synthase 3 | |
| NP_001039457.1 | 0 | 0 | 9 | Neugrin | |
| 1Z2W | 0 | 0 | 8 | Vacuolar protein sorting-associated protein 29 | |
| ACD50133.1 | 0 | 0 | 8 | Interleukin-1 receptor-associated kinase 2 transcript variant 1 | |
| NP_001096812.1 | 0 | 0 | 8 | TSC22D3 protein | |
| AAB35870.1 | 0 | 0 | 7 | Dual specificity protein phosphatase | |
| BAD92273.1 | 0 | 0 | 7 | Proteasome 26S ATPase subunit 5 variant | |
| NP_001033273.1 | 0 | 0 | 7 | Retrograde Golgi transport protein RGP1 homolog | |
| NP_001033592.1 | 0 | 0 | 7 | Translocon-associated protein subunit delta | |
| NP_001039816.1 | 0 | 0 | 7 | Thyroid hormone receptor interactor 4 | |
| NP_001071580.1 | 0 | 0 | 7 | Acyl-CoA synthetase family member 2, mitochondrial | |
| XP_001366185.1 | 0 | 0 | 7 | Metastasis-associated protein MTA2 | |
| XP_001367952.1 | 0 | 0 | 7 | Heterogeneous nuclear ribonucleoprotein A0 | |
| XP_001790184.1 | 0 | 0 | 7 | Ubiquitin carboxyl-terminal hydrolase 30 | |
| NP_001029777.1 | 0 | 0 | 6 | KxDL motif-containing protein 1 | |
| AAV97884.1 | 0 | 0 | 5 | Mitogen-activated protein kinase kinase kinase kinase 4 isoform | |
| BAG53140.1 | 0 | 0 | 5 | Mortality factor 4-like protein 1 | |
| CAA28542.1 | 0 | 0 | 5 | Clathrin light chain A | |
| EDM09101.1 | 0 | 0 | 5 | eukaryotic translation initiation factor 4E binding protein 1 | |
| NP_001001598.1 | 0 | 0 | 5 | Prolyl 4-hydroxylase subunit alpha-3 | |
| NP_001030280.1 | 0 | 0 | 5 | Cytosolic non-specific dipeptidase | |
| NP_001039878.1 | 0 | 0 | 5 | 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial | |
| NP_001068735.1 | 0 | 0 | 5 | Canopy 2 homolog (Zebrafish) | |
| NP_001068999.1 | 0 | 0 | 5 | Thiopurine S-methyltransferase | |
| NP_001076071.1 | 0 | 0 | 5 | DDX41 protein | |
| XP_001102980.1 | 0 | 0 | 5 | Spermatogenesis-defective protein 39 homolog | |
| XP_001170347.1 | 0 | 0 | 5 | NA* | |
| XP_001251315.2 | 0 | 0 | 5 | Small integral membrane protein 3 | |
| XP_001492130.2 | 0 | 0 | 5 | Reticulocalbin-3 | |
| XP_611630.4 | 0 | 0 | 5 | Collagen alpha-1(XII) chain | |
| XP_849800.1 | 0 | 0 | 5 | NA* | |
| ZP_01925762.1 | 0 | 0 | 5 | NA* |
NA*: This record was removed from NCBI as a result of standard genome annotation processing.
Figure 4mRNA expression of genes identified with higher EST numbers.
C2C12 cells treated with differentiation and transdifferentiation media at 80% confluence were harvested at different time points. Real time PCR was carried out with cDNA synthesized from1µg of total RNA. mRNA expression analysis of most of the genes showed more than 2 fold induction during MFCs (A) and ALCs (B) formation, respectively. Western blot analysis of DDAH2 shows a gradual increase in protein expression with time (C). Cellular localization of DDAH2 by immunocytochemistry during myogenesis. The first column shows cell pictures at Day 0 and Day 3. The second column shows expression of DDAH2 and the third column shows a merged image of DAPI-stained nuclei and DDAH2 IF (D).Western blot analysis of HBA2 expression during transdifferentiation confirms its protein level expression (E). Cytoplasmic localization of HBA2 by immunocytochemistry during transdifferentiation. The first column shows cell pictures at Day 0 and Day 2, the second column shows expression of HBA2 IF and the third column shows a merged image of DAPI-stained nuclei and HBA2 IF (F). DDAH2 and HBA2 immunohistochemistry of bovine skeletal muscle (G and H). Day 0 represents control (mean ± S.D., n= 3). p-value indicates the statistical significance of the data and different letters show significant differences among groups.
Figure 5DDAH2 knockdown in C2C12 cells during myogenesis.
mRNA expression of DDAH2 and MYOG after DDAH2 kd during differentiation in C2C12 at Day 2 (A). Representative cell picture showing morphological changes in DDAH2 kd cells (B). Mock represents control (mean ± S.D., n= 3). p-value indicates the statistical significance of the data and different letters show significant differences among groups.
Figure 6HBA2 knockdown in C2C12 cells during transdifferentiation.
(A) mRNA expression of HBA2 after HBA2 kd during transdifferentiation in C2C12 at Day 1, and (B) HBA2 kd effect on mRNA expression of different adipogenic marker genes.(C) Cell picture following intracellular lipid staining by O-R-O on Day 5 during transdifferentiation in HBA2kd and Mock cells. Quantification of O-R-O at 510 nm. Control represents Mock (mean ± S.D., n= 3). p-value indicates the statistical significance of the data and different letters show significant differences among groups.